, Author at HistoIndex

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024 SINGAPORE, Nov. 8, 2024 /PRNewswire/ — HistoIndex, a pioneering leader in artificial intelligence (AI) and stain-free digital pathology, will present its latest research findings and advancements in AI-based analysis at the 75th The …

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024 Read More »

Revolutionizing MASH Diagnosis: The Role of AI in Digital Pathology

Blog / By SEM CCM

Understanding MASH and Its Impact on Liver Health As liver diseases such as Metabolic-Associated Steatohepatitis (MASH) continue to rise worldwide, the need for more accurate, efficient diagnostic tools has become increasingly urgent. Traditional diagnostic methods, including biopsies and stain-based histology, come with limitations that can hinder timely and precise assessments. However, the landscape of liver …

Revolutionizing MASH Diagnosis: The Role of AI in Digital Pathology Read More »

Comparative Analysis: Stain-Free vs. Traditional Staining Imaging

Blog / By SEM CCM

Introduction In the evolving landscape of medical research and diagnostics, histopathology plays a pivotal role in the accurate assessment of diseases like cancer and fibrosis. Histopathology, the study of tissue changes caused by disease, depends heavily on imaging techniques to visualize the intricate structures within tissues. These techniques, whether traditional or innovative, are essential in …

Comparative Analysis: Stain-Free vs. Traditional Staining Imaging Read More »

Exploring the Potential of GLP-1 Agonists in MASH

Blog / By SEM CCM

Introduction Metabolic-associated steatohepatitis (MASH) represents a significant health burden worldwide. This liver condition is strongly associated with obesity, type 2 diabetes, and other metabolic disorders. As research into metabolic health advances, GLP-1 agonists have emerged as a promising treatment for these conditions, extending their therapeutic benefits beyond diabetes and obesity management. This article explores the …

Exploring the Potential of GLP-1 Agonists in MASH Read More »

Navigating Liver Fibrosis: Innovations in Imaging and Detection

Blog / By SEM CCM

Introduction Liver fibrosis, a progressive scarring of the liver tissue, is a critical condition that often develops due to chronic liver diseases such as hepatitis, alcohol abuse, or Metabolic dysfunction–associated steatotic liver disease (MASLD). The progression of liver fibrosis can lead to poor patient outcomes like, cirrhosis and liver failure, making early detection and accurate …

Navigating Liver Fibrosis: Innovations in Imaging and Detection Read More »

Integration of Quantitative Pathology Analysis in Drug Development & Patient Treatment

Blog / By SEM CCM

Introduction Pathology, the cornerstone of medical diagnosis, has witnessed a transformative evolution from its traditional roots to leveraging cutting-edge digital technology. This shift has not only refined diagnostic accuracy but has fundamentally altered the landscape of medical research, clinical trials, and patient care. Quantitative pathology, a pivotal component of this digital transition, employs advanced imaging …

Integration of Quantitative Pathology Analysis in Drug Development & Patient Treatment Read More »

Stain-Free Tissue Imaging: Advancing Fibrosis Research

Blog / By SEM CCM

Introduction Advanced imaging techniques play a crucial role in furthering our understanding of fibrotic diseases. Among these, stain-free tissue imaging is emerging as a valuable tool in fibrosis research. This category of imaging methods, including techniques like Second Harmonic Generation (SHG) microscopy, offers an alternative approach to visualizing tissue structures without using traditional chemical stains. …

Stain-Free Tissue Imaging: Advancing Fibrosis Research Read More »

New: Our latest case study on qFibrosis' role in the successful development of Rezdiffra

Author name: SEM CCM

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024

Revolutionizing MASH Diagnosis: The Role of AI in Digital Pathology

Comparative Analysis: Stain-Free vs. Traditional Staining Imaging

Exploring the Potential of GLP-1 Agonists in MASH

Navigating Liver Fibrosis: Innovations in Imaging and Detection

Integration of Quantitative Pathology Analysis in Drug Development & Patient Treatment

Stain-Free Tissue Imaging: Advancing Fibrosis Research

Connect with us

Pages

Locations